January 24, 2023
Bacitracin Ophthalmic Ointment is indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by Bacitracin susceptible organisms. Padagis EVP & Chief Commercial Officer, John Wesolowski stated: “Padagis invested deeply in its supply chain to bring this important therapy back to market. The Padagis team continues to leverage our unique and specialized technical and commercial capabilities to deliver important products to our customers and patients.”
Padagis is a leading provider of extended topical and other specialty pharmaceuticals to its primary markets of the United States and Israel. Padagis employs over 1,300 people worldwide.